Vestibular Involvement in Systemic Lupus Erythematosus

Clinical Presentation and Diagnosis

Cranial neuropathy affecting the eighth cranial nerve is a recognized neuropsychiatric manifestation of SLE, occurring in 1-5% of patients, according to the American College of Rheumatology 1, 2
The diagnostic work-up should parallel evaluation of non-SLE patients with similar manifestations, then secondarily attribute findings to lupus activity, as recommended by the European League Against Rheumatism 3, 4
Brain MRI is essential to exclude brainstem stroke, meningitis, or structural lesions, and may show focal abnormal signal intensity in the medulla oblongata in cases with central vertigo, as suggested by the American College of Radiology 1, 2, 5
CSF analysis is necessary to exclude CNS infection, particularly when fever or systemic symptoms are present, according to the Infectious Diseases Society of America 1, 2

Glucocorticoids and immunosuppressive therapy are indicated when cranial neuropathy is thought to reflect an inflammatory process, particularly in the presence of concurrent generalized lupus activity, as recommended by the American College of Rheumatology 1, 3, 4, 6
Pulse intravenous methylprednisolone in combination with intravenous cyclophosphamide is the recommended regimen for severe cranial neuropathy, with response rates of 60-75%, according to the European League Against Rheumatism 1
Chronic immunosuppressive therapy is necessary given the 50-60% relapse rate during corticosteroid dose reduction, and options include azathioprine, mycophenolate mofetil, or continued cyclophosphamide, as suggested by the American College of Rheumatology 1, 7

Clinical improvement should occur within days to 3 weeks with appropriate immunosuppressive therapy, and neurological response should parallel improvement in systemic disease activity, according to the American College of Rheumatology 1
Brain SPECT imaging may help monitor treatment response in selected cases, as recommended by the Society of Nuclear Medicine and Molecular Imaging 8
Extensive MRI lesions, reduced muscle strength, sphincter dysfunction, antiphospholipid antibodies, and delayed treatment initiation (>2 weeks) are associated with severe neurological deficits, according to the American Academy of Neurology 1